New horizons in prevention and treatment of ischaemic injury to kidney transplants

Nephrology Dialysis Transplantation

Volumn 22, Issue 2, 2007, Pages 342-346

  Aydin, Zeynep ^a   van Zonneveld, Anton J ^a   de Fijter, Johan W ^a   Rabelink, Ton J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Erythropoietin; Glitazones; Ischemia reperfusion injury stem cells; Kidney donor

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; HEAT SHOCK PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 10; LIPOSOME; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; OLIGODEOXYNUCLEOTIDE; PADGEM PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; SCATTER FACTOR; SOMATOMEDIN C; TEPRENONE; VASCULOTROPIN;

CANCER; CELL METABOLISM; CLINICAL TRIAL; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; DRUG RESEARCH; ENDOTHELIUM CELL; HUMAN; HYPOXEMIA; ISCHEMIC PRECONDITIONING; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY METABOLISM; KIDNEY PERFUSION; KIDNEY TRANSPLANTATION; MESENCHYMAL STEM CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENAL PROTECTION; REPERFUSION INJURY; REVIEW; SHORT COURSE THERAPY; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PROGNOSIS; REPERFUSION INJURY;

EID: 33846660515     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl690     Document Type: Review

References (49)

1. Keizer KM, de Fijter JW, Haase-Kromwijk BJ, Weimar W. Non-heart-beating donor kidneys in the Netherlands: Allocation and outcome of transplantation. Transplantation 2005; 79: 1195-1199
2. Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995; 332: 647-655
3. Rosenberger C, Heyman SN, Rosen S et al. Up-regulation of HIF in experimental acute renal failure: Evidence for a protective transcriptional response to hypoxia. Kidney Int 2005; 67: 531-542
4. Bach FH. Heme oxygenase-1: A therapeutic amplification funnel. FASEB J 2005; 19: 1216-1219
5. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17: 1503-1520
6. Guijarro C, Egido J. Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int 2001; 59: 415-424
7. Tsuchibashi S, Ke B, Kaldas F et al. Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injury. Am J Pathol 2006; 168: 695-705
8. Linden J. Adenosine in tissue protection and tissue regeneration. Mol Pharmacol 2005; 67: 1385-1387
9. Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006; 70: 181-190
10. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004; 66: 486-491
11. Gailit J, Colflesh D, Rabiner I, Simone J, Goligorsky MS. Redistribution and dysfunction of integrins in cultured renal epithelial cells exposed to oxidative stress. Am J Physiol 1993; 264: F149-F157
12. Wangsiripaisan A, Gengaro PE, Edelstein CL, Schrier RW. Role of polymeric Tamm-Horsfall protein in cast formation: Oligosaccharide and tubular fluid ions. Kidney Int 2001; 59: 932-940
13. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210
14. Wang S, Hirschberg R. Role of growth factors in acute renal failure. Nephrol Dial Transplant 1997; 12: 1560-1563
15. Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: Role of A(1) and A(3) receptors. Am J Physiol Renal Physiol 2000; 278: F380-F387
16. Linden J. Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 2001; 41: 775-787
17. Bernhardt WM, Campean V, Kany S et al. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure. J Am Soc Nephrol 2006; 17: 1970-1978
18. Minowada G, Welch WJ. Clinical implications of the stress response. J Clin Invest 1995; 95: 3-12
19. Suzuki S, Maruyama S, Sato W et al. Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70. Kidney Int 2005; 67: 2210-2220
20. Brines M, Cerami A. Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise. Kidney Int 2006 70: 246-250
21. Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 2005; 6: 484-494
22. Sharples EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2115-2124
23. Erbayraktar S, Grasso G, Sfacteria A et al. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci USA 2003; 100: 6741-6746
24. Brines M, Grasso G, Fiordaliso F et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA 2004; 101: 14907-14912
25. Kelly KJ, Williams Jr WW, Colvin RB et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97: 1056-1063
26. Ichikawa H, Flores S, Kvietys PR et al. Molecular mechanisms of anoxia/ reoxygenation-induced neutrophil adherence to cultured endothelial cells. Circ Res 1997; 81: 922-931
27. Vos IH, Govers R, Grone HJ et al. NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J 2000; 14: 815-822
28. Salmela K, Wramner L, Ekberg H et al. A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: A report of the European Anti-ICAM-1 Renal Transplant Study Group. Transplantation 1999; 67: 729-736
29. Furuya K, Takeda H, Azhar S et al. Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: A bedside-to-bench study. Stroke 2001; 32: 2665-2674
30. Beiras-Fernandez A, Chappell D, Hammer C, Thein E. Influence of polyclonal anti-thymocyte globulins upon ischemia-reperfusion injury in a non-human primate model. Transpl Immunol 2006; 15: 273-279
31. Yamauchi J, Schramm R, Richter S et al. Improvement of microvascular graft equilibration and preservation in non-heart-beating donors by warm preflush with streptokinase. Transplantation 2003; 75: 449-453
32. Lemberger T, Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 1996; 12: 335-363
33. Martens FM, Visseren FL, Lemay J, de Koning EJ, Rabelink TJ. Metabolic and additional vascular effects of thiazolidinediones. Drugs 2002; 62: 1463-1480
34. Chawla A, Barak Y, Nagy L et al. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 2001; 7: 48-52
35. Jackson SM, Parhami F, Xi XP et al. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leucocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol 1999; 19: 2094-2104
36. Pascual G, Fong AL, Ogawa S et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 2005; 437: 759-763
37. Brodsky SV, Yamamoto T, Tada T et al. Endothelial dysfunction in ischemic acute renal failure: Rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 2002; 282: F1140-F1149
38. Haendeler J, Dimmeler S. Inseparably tied: Functional and antioxidative capacity of endothelial progenitor cells. Circ Res 2006; 98: 157-158
39. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ et al. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001; 357: 33-37
40. Heeschen C, Aicher A, Lehmann R et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003; 102: 1340-1346
41. Rabelink TJ, de Boer HC, de Koning EJ, van Zonneveld AJ. Endothelial progenitor cells: More than an inflammatory response? Arterioscler Thromb Vasc Biol 2004; 24: 834-838
42. Liu Y, Yang J. Hepatocyte growth factor: New arsenal in the fights against renal fibrosis? Kidney Int 2006; 70: 238-240
43. Mizuno S, Nakamura T. Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am J Pathol 2005; 166: 1895-1905
44. Mizui M, Isaka Y, Takabatake Y et al. Electroporation-mediated HGF gene transfer ameliorated cyclosporine nephrotoxicity. Kidney Int 2004; 65: 2041-2053
45. Devarajan P. Has HGF met other partners? Met-independent epithelial morphogenesis induced by HGF. focus on 'hepatocyte growth factor induces MDCK cell morphogenesis without causing loss of tight junction functional integrity'. Am J Physiol Cell Physiol 2004; 286: C475-C477
46. Cao R, Brakenhielm E, Pawliuk R et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003; 9: 604-613
47. Jiang XX, Zhang Y, Liu B et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005; 105: 4120-4126
48. Lange C, Togel F, Ittrich H et al. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 2005; 68: 1613-1617
49. Nauta AJ, Westerhuis G, Kruisselbrink AB et al. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006; 108: 2114-2120